Prosecution Insights
Last updated: October 02, 2026

Saro Research LLC

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Saro Research LLC currently manages 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This action is concentrated under a distinct examiner and a distinct art unit, which creates a focused prosecution footprint. For a company in this sector, the current examiner concentration means that the outcome of the portfolio rests on the interpretation of a specific individual. The busiest examiner for this portfolio is BOWERS, NATHAN ANDREW, who is responsible for 1 busiest examiner pending action.

Because this represents the entirety of the pending workload, the prosecution strategy is tethered to the specific preferences and historical tendencies of this official. Practitioners should focus on the specific requirements of the distinct art unit involved to navigate the remaining office action effectively. The concentration of the pending office action in the distinct art unit suggests that the underlying technology is specialized within a niche of Biotechnology & Pharmaceuticals.

With only the distinct examiner involved, there are no alternative prosecution paths or varied examiner perspectives to compare within the current data set. This centralized workload requires a precise response to the pending office action to avoid potential delays in this specific art unit.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
0
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
1
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
BOWERS, NATHAN ANDREW 1 59.4% +31.9%

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18110333 METHODS OF RECOVERING RARE EARTH METALS BOWERS, NATHAN ANDREW —

Top Art Units

Art UnitApps
1656 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18110333 METHODS OF RECOVERING RARE EARTH METALS BOWERS, NATHAN ANDREW 1656 §103 Final Rejection — Pending Feb 15, 2023

Managing Saro Research LLC's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month